SEC Tracker
Get the app

Lucid Diagnostics LUCD

Lucid Diagnostics: signs a material agreement, takes on a new financial obligation and 2 other items

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
  • Signs a material agreement (1.01)
  • Takes on a new financial obligation (2.03)
  • Sells unregistered shares (3.02)
  • Changes shareholder rights (3.03)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Lucid Diagnostics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Apyx Medical APYX public float $80M, Jun 30, 2025
  2. Encision ECIA
  3. Accuray ARAY public float $87M, Dec 31, 2025
  4. TELA Bio TELA public float $77M, Jun 30, 2025
  5. enVVeno Medical NVNO public float $76M, Jun 30, 2025